Proactive research analyst says Tiziana Life Sciences "moving forward quite nicely"
By:
TheNewswire.com
February 09, 2023 at 05:24 AM EST
Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a 2023 Clinical Outlook for clinical stage biotechnology company Tiziana Life Sciences Ltd (NASDAQ: TLSA). He gives his take on what the market can expect from the business this year, saying that it is now "moving forward quite nicely."
Contact Details
Proactive UK Ltd
Proactive UK Ltd
+44 20 7989 0813
More News
View More
MP Materials Stock Soared After Earnings—Here’s the Real Reason ↗
November 22, 2025
Via MarketBeat
Why Palantir Slide May Be a Setup for a Long-Term Opportunity ↗
November 22, 2025
Via MarketBeat
Attention Income Investors: This REIT Is on Sale ↗
November 22, 2025
Rocket Lab Just Had Its First Real Crash—The Rebound Could Be Bigger ↗
November 22, 2025
Via MarketBeat
Tickers
RKLB
MarketBeat Week in Review – 11/17 - 11/21 ↗
November 22, 2025
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>